TY - JOUR AB - Necrolytic migratory erythema (NME), diabetes mellitus and glucagon-secreting tumors form the hallmarks of glucagonoma syndrome, and represent the major clinical manifestations of glucagonoma. NME is usually presented as the initial complaint of patients. Due to the rare incidence of glucagonoma, its diagnosis is often delayed, which leads to its progression. Here, we report a case of NME with a typical skin rash, which was misdiagnosed and treated with corticosteroids for two years. Removal of the tumor in the pancreatic body led to the rapid relief of the symptoms. The aim of the present study is to demonstrate the typical characteristics of glucagonoma syndrome to clinicians in order to improve its diagnosis and treatment. AD - The Pancreas Center of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China Department of Pathology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China AU - Wei,Jishu AU - Lin,Shibo AU - Wang,Cong AU - Wu,Junli AU - Qian,Zhuyin AU - Dai,Cuncai AU - Jiang,Kuirong AU - Miao,Yi DA - 2015/08/01 DO - 10.3892/ol.2015.3275 EP - 1116 IS - 2 JO - Oncol Lett KW - necrolytic migratory erythema diabetes mellitus glucagonoma PY - 2015 SN - 1792-1074 1792-1082 SP - 1113 ST - Glucagonoma syndrome: A case report T2 - Oncology Letters TI - Glucagonoma syndrome: A case report UR - https://doi.org/10.3892/ol.2015.3275 VL - 10 ER -